Zura Bio Ltd. has announced the adoption of a new Executive Severance Benefit Plan, extending enhanced severance benefits to certain employees, including the company's current named executive officers. Under the plan, the Chief Executive Officer is eligible for a lump sum payment equal to 12 months of base salary if terminated without cause or resigning for good reason, while other named executive officers are eligible for nine months of base salary. In the event of a termination within 12 months following a change in control, the CEO would receive 18 months of base salary and 150% of their target annual bonus, along with a prorated annual bonus and up to 18 months of COBRA premium reimbursement. Other named executive officers would be entitled to 12 months of base salary, 100% of their target annual bonus, a prorated annual bonus, and up to 12 months of COBRA reimbursement.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zura Bio Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-25-095024), on September 30, 2025, and is solely responsible for the information contained therein.
Comments